Details

Last Funding Type

Post-IPO Debt

Last Funding Money Raised

€30M

Industries

Health Care,Manufacturing,Medical,Medical Device

Founded date

Jan 1, 2008

Number Of Employee

501 - 1000

Operating Status

Active

CARMAT is a medtech company that develops and manufactures bioprosthetic artificial hearts for the healthcare industry. The company is offering biocompatible, auto-regulated total artificial hearts, including right and left ventricles designed to be as close as possible to the human heart. It is designed for patients suffering from chronic terminal heart failure reaching class IV on the New York Heart Association classification; or acute terminal heart failure following a massive myocardial infarction.

CARMAT’s aim is to offer a reliable new treatment and innovative therapeutic solution to heart failure patients, who are not eligible for a transplant and who have exhausted every drug-related possibility. It was launched in 2008 and is based in Vélizy-villacoublay.